Dr. Pouya Afshar is board certified in internal medicine, hospice and palliative medicine, and venous and lymphatic medicine. Since 2010 he has served as an assistant clinical professor of medicine at the University of California, San Diego. He works in different levels of healthcare in an effort to provide continuity of care for all his patients.
As an acute care physician, Dr. Afshar is a hospitalist at UCSD Thornton, UCSD Hillcrest, Scripps Mercy Hospital, and the VA San Diego Hospital. A pioneer in transitional care medicine, Dr. Afshar is a medical director for several skilled nursing facilities, where he manages patients’ post-hospitalization during their short-term rehabilitation.
Dr. Afshar founded Integrated Healthcare Alliance (IHA) in 2015, where his primary care physicians lead a multidisciplinary team that delivers in-home medical care.
Outside of medicine, Dr. Afshar is an avid soccer player, former personal trainer, and completed 14 marathons, including two trips as a qualifying runner for the Boston Marathon
Chris has been involved in the medical and biotechnology industry for more than 25 years. Chris is a co-founder and CEO of Integrated Healthcare Management Organization, Inc (IHM) which operates as the exclusive management service organization to the Integrated Healthcare Alliance (IHA). Chris is also a co-founder (2014) and CEO of Paracrine, formerly Celactive Cellular Therapeutics Limited, a company focused on in-licensing and developing novel cell therapy technology for cardiovascular conditions and specifically for heart failure.
Chris was a co-founder of Cytori Therapeutics, Inc. (NASDAQ: CYTX; initially formed as Macropore, Inc.) and was CEO & Vice-Chairman of the Board between June 1996 and April 2014. During his tenure with Cytori, he brought in more than $400 million in investment, partnerships, and divestitures as well as creating partnerships with multiple leading device and pharmaceutical companies including GE Healthcare, Olympus Medical, Medtronic, Astellas Pharma, Senko Medical, Kensey Nash, Green Hospital Supply, Lorem Vascular, Kerastem, and Mast Biosurgery as well as established a contract with the US Government (BARDA) worth up to $106 million.
Chris took MacroPore public in Germany on the Neuer Markt and later the Deutsche Borse: “XMP” and later listed Cytori on NASDAQ: CYTX. Chris is a co-founder and Chairman of the Board of LeonardoMD, a prior board member of Artes Medical, Inc., an advisory board member of Targazyme, Inc. and has served as a founding member on the board and executive committee of the Alliance for Regenerative Medicine. He was also the creator and founder of the non-profit organization Cell Society, which was the first organization to bring together international cell therapy stakeholders with a clinical focus including multidisciplinary specialties to cross-fertilize the advancing field actively treating patients around the world.
Chris is an inventor on more than 96 medical product patent applications and has brought numerous medical device products through the FDA to market in the US as well as in Europe, Japan, China and many other markets around the world. He has presented at more than 100 regenerative medicine, technology and financial conferences around the world and has been an invited lecturer in entrepreneurship and biotechnology at both the Anderson School of Management at UCLA and Rady’s School of Management at UCSD. Chris has an undergraduate degree from the University of California at San Diego in Economics and an MBA from the University of Phoenix.
As President and Head of Clinical Operations at Integrated Healthcare Alliance, Ash has developed and implemented the processes necessary to take care of America’s sickest patients in a seamless, effective, and cost-efficient manner.
With his broad skill base, Ash has brought to IHA his years of experience in process development and data analysis, health-related quality improvement, clinical expertise in acute care practices, and health policy analysis.
After graduating from UCLA with a BS in physiological sciences with emphasis on mathematical modeling of physiological systems, Ash went to the University of California, Irvine where he received his Medical Degree. He subsequently moved to San Diego where he has been practicing medicine with experience in Hospital Medicine, Urgent Care Medicine, and Post Acute Medicine.
Most recently, Ash graduated from the University of San Diego with a Juris Doctorate in June of 2018. He was involved in an audit of the Board of Registered Nursing workings from 2017 to 2018 under the direction of the Center for Public Interest Law at USD.
Ash’s passion is to utilize his extensive skills and experience to bring healthcare to those in need and those too complicated to be taken care of by America’s current healthcare system in a cost-efficient manner. Integrated Healthcare Alliance serves as the vehicle in accomplishing this goal.